Jump to content

Fluoxetine

From Pharmacopedia
Revision as of 06:40, 20 May 2026 by Noob (talk | contribs) (Added Problem: Embarrassment)
SSRI, Anxiolytic, Antidepressant
Fluoxetine
Prozac
Fluoxetine was the first of a long line of SSRIs. It is notable for its extremely long half-life and relative lack of withdrawal syndrome. It can also be useful in helping taper and discontinue other SxRI meds.

Experience

👥 No personal reports yet
1 provider report · avg efficacy 40.0/100 · avg side-effect burden 40.0/100 · 150 patients managed total

Log in to add your own experience.

Problems

Depressive disorders1.1n=1
Anxiety disorders broadly1.5n=2
Including generalized anxiety, panic, and social anxiety.
Panic disorder1.5n=2
Social anxiety disorder2.0n=1
Obsessive-compulsive disorder3.0n=1
PTSD1.0n=1
Potentially.
Premature ejaculation2.1n=2
Embarrassment0.5n=3
I was very embarrassed when I told somebody I was using it.
+ Add a problem

Titration strategies

Standard adult or child+1
Start no higher than 10 mg for the first dose. May increase by 10 mg every 2–12 weeks, or remain at 10 mg if the response is adequate, up to a typical starting maximum of 40 mg. Absolute max: 80 mg.
OCD+1
Start at 10 mg daily; increase by 10–20 mg every 2–6 weeks, up to 80 mg. OCD typically requires elevated doses (60–80 mg).

+ Add a titration strategy

Effects

  • Anxiolysis👤 no reports yet⚕️ ~33% +67.0 (n=1)
    Classically starting at 3–4 weeks and improving for another 8–12.
  • Delayed orgasm/ejaculation👤 0% (n=3)⚕️ ~80% +33.0 (n=1)
  • Mood enhancement👤 no reports yet⚕️ ~5% +67.0 (n=1)
  • Nausea👤 no reports yet⚕️ ~5% -33.0 (n=1)
    Common, often improves over 1–2 weeks.
  • Decreased libido👤 no reports yet⚕️ ~33% -100.0 (n=1)
  • Temporary erectile dysfunction👤 no reports yet⚕️ ~20% -67.0 (n=1)
  • Persistent Sexual Dysfunction👤 no reports yet⚕️ ~0% -100.0 (n=1)
    Historically associated with SSRIs.
Anorgasmia👤 no reports yet⚕️ ~5% -100.0 (n=1)

+ Add an effect

Pharmacokinetics

Absorption

70–90%[3] oral bioavailability.

Distribution

Fluoxetine has plasma protein binding of approximately 94.5%, bound to albumin and alpha-1 glycoprotein. Fluoxetine readily crosses the blood–brain barrier, with a brain-to-plasma ratio of 2.6:1 in humans. The volume of distribution (Vd) of fluoxetine and its metabolite ranges between 20 to 42 L/kg. Some studies report that fluoxetine has the maximum volume of distribution (Vd) of any SSRI (between 14 and 100 L/kg).[3]

Metabolism

Fluoxetine's active metabolite is norfluoxetine, produced when the cytochrome P450 enzyme (CYP2D6) acts on it. Prescribers must remember that fluoxetine has several med-med interactions due to its metabolism through the CYP2D6 isoenzyme. Additionally, norfluoxetine can have an inhibitory effect on CYP3A4. Fluoxetine has a half-life of 2 to 4 days, and its active metabolite norfluoxetine has a half-life of 7 to 9 days. Approximately 7% of individuals definitively exhibit poor metabolism of fluoxetine due to reduced activity of CYP2D6.[3]

Interactions

Pharmacogenomic + mechanism interactions5 edges
Pharmacokinetic mechanismSubstrate / metabolism relationships from primary literature
Enzyme:CYP2D6 inhibitor strong Primary 90 / 100
FDA Drug Interactions Table: strong index inhibitor of CYP2D6.
mechanism-based, interaction persists ~4-6 weeks after stopping the inhibitor
Inferred from pharmacokinetic dataMaterialised by the inference engine; provenance shown per row
Codeine pk lowers via CYP2D6 Inferred 90 / 100
Fluoxetine inhibits CYP2D6 (inhibitor_strong, intensity 90); Codeine is a prodrug_activated_by of CYP2D6 (intensity 100). Derived: Codeine exposure lowered.
mechanism-based, interaction persists ~4-6 weeks after stopping the inhibitor
Inferred via Enzyme:CYP2D6 (exposure lowered)
Nebivolol pk raises via CYP2D6 Inferred 72 / 100
Fluoxetine inhibits CYP2D6 (inhibitor_strong, intensity 90); Nebivolol is a substrate_major of CYP2D6 (intensity 80). Derived: Nebivolol exposure raised.
mechanism-based, interaction persists ~4-6 weeks after stopping the inhibitor
Inferred via Enzyme:CYP2D6 (exposure raised)
Desipramine pk raises via CYP2D6 Inferred 72 / 100
Fluoxetine inhibits CYP2D6 (inhibitor_strong, intensity 90); Desipramine is a substrate_major of CYP2D6 (intensity 80). Derived: Desipramine exposure raised.
mechanism-based, interaction persists ~4-6 weeks after stopping the inhibitor
Inferred via Enzyme:CYP2D6 (exposure raised)
Dextromethorphan pk raises via CYP2D6 Inferred 72 / 100
Fluoxetine inhibits CYP2D6 (inhibitor_strong, intensity 90); Dextromethorphan is a substrate_major of CYP2D6 (intensity 80). Derived: Dextromethorphan exposure raised.
mechanism-based, interaction persists ~4-6 weeks after stopping the inhibitor
Inferred via Enzyme:CYP2D6 (exposure raised)

Patient experience

MDMA👤 exp n/a/5 outcome n/a (n=1)⚕️ exp 3.0/5 outcome -33.0 (n=1)
Antidepressants👤 exp n/a/5 outcome n/a (n=1)⚕️ exp 1.0/5 outcome +33.0 (n=1)
Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs)👤 no reports yet⚕️ exp 4.0/5 outcome +33.0 (n=1)

Monitoring

None required

Relevant anecdote

⚕️ Provider by MDElliottMD0
Fluoxetine is great for getting off other SxRIs! Especially venlafaxine and duloxetine.

+ Add an anecdote

Relevant Literature

No literature entries yet.

Log in to submit relevant literature.

See also

Sertraline, Duloxetine

References

  1. S1
  2. S0
  3. 3.0 3.1 3.2 S3
Structure of Fluoxetine
Summary
Classes
SSRI, Anxiolytic, Antidepressant
Common uses
+ 3 more uses →
Pharmacy
Starting dose
10 mg
Preparations
10 mg, 20 mg, 40 mg caps
US FDA Max
40 mg/d
Pill ID
  • 10 mg: green/cream capsule, "PLIVA 647"
  • 20 mg: green/cream capsule, "PROZAC 20"
  • 40 mg: olive/cream capsule, "DISTA 3107"
  • Oral solution: 20 mg / 5 mL, clear
Pharmacology
Routes
Oral
Duration
Very long
Half-life
1–4 days (7–15 days for norfluoxetine)
Bioavailability
70–90% (oral)
Pregnancy
Category C[2]
Legal status
Rx-only in US
Purported mechanism
TrkB/BDNF[1] Fluoxetine is a selective serotonin reuptake inhibitor.0